How can we accelerate successful drug discovery and development?
The success of clinical candidate development depends on several factors, important among them are generation of novel, therapeutically-relevant chemical structures, early and rapid assessment of possible efficacy of candidate structures in pre-clinical therapeutic models and rapid elimination of candidates that will ultimately prove unsuccessful. Innovative processes and techniques that facilitate optimal candidate selection is a crucial step in accelerating drug discovery and development timelines.
Join us on Thursday, June 14, 2018 for an afternoon of lunch, insightful presentations and discussion, followed by a networking and happy hour reception.
11:30 AM- 12:30 PM
Registration & Lunch, Opening Remarks
12:30 PM- 4:50 PM
4:50 PM- 5:00 PM
5:00 PM- 6:00 PM
Networking Reception and Happy Hour
We look forward to seeing you in San Diego!
Thursday, June 14, 2018
11:30 AM- 6:30 PM PDT
Farmer & the Seahorse
10996 Torreyana Rd
San Diego, CA 92121
This event is free to attend, but space is limited. Reserve a seat today!
Why Bother? Impact of Downstream Development and Market Considerations on Discovery Projects
Vince Wacher, Ph. D. | Product Planning and Development
The ReFRAME Drug Repositioning Library: Building and Applications to Neglected Diseases
Arnab Chatterjee, Ph. D. | VP Medicinal Chemistry | Calibr
Paving the Road to the Clinic: Advancing Oncology Drug Development with Translational In Vitro and In Vivo Models
Tommy Broudy, Ph. D. | CEO | Molecular Response
BioDuro Solution Engine: Enabled Formulations Bridging Discovery and Development
Blair West, Ph. D. | CSO, Global CMC Solutions | BioDuro
Development of Poorly Soluble Compounds: Discovery to FIH and Later Clinical Development Phases
Hamid Rezai, Ph. D. | Senior Director of Pharmaceutics | Plexxikon Inc.
Reactive Melt Extrusion to Improve Properties of Amorphous Solid Dispersions
Feng Zhang, Ph. D. | Assistant Professor of Pharmaceutics | University of Texas at Austin